Corporate Governance Homepage Investors Corporate Governance Guerbet is a limited liability company incorporated under the laws of France with securities listed on Euronext Paris, France. Consequently, our corporate governance framework reflects the mandatory provisions of French corporate law, the securities laws and regulations applying to Guerbet as a corporation listed in France States. In addition, the Company’s corporate governance principles refer to the AFEP-MEDEF Code. On May 21, 2010, Guerbet adopted the French form of a joint stock company governed by a Board of Directors (Société Anonyme à Conseil d'administration). This legal structure upholds a clear separation between management functions assumed by the Executive Committee and the functions of oversight assured by the Board of Directors, which represents the shareholders. Board of Directors Marie-Claire Janailhac-Fritsch Chairwoman of the Board Marion Barbier Director Olivier Fougère Employee Director Mark Fouquet Director Eric Guerbet Director Didier Izabel Director Céline Lamort Director Nicolas Louvet Director Marc Massiot Director Claire Massiot-Jouault Director Jean-Sébastien Raynaud Employee Director Thibault Viort Director Executive Committee David Hale Chief Executive Officer Jean-François Blanc SVP Interventional Imaging Philippe Bourrinet SVP Development, Medical & Regulatory Affairs and Group Responsible Pharmacist Valérie Brissart SVP Diagnostic Imaging Sarah Dayre SVP Technical Operations and Interim Responsible Pharmacist Mathieu Elie Chief Commercial Officer Asia Pacific Jérôme Estampes Chief Financial Officer and SVP Business Development & Licensing Gitte Hesselholt Chief Commercial Officer Americas & EMEA François Nicolas SVP R&D, R&I and Chief Digital Officer Pétra Zalabak SVP Human Resources & Corporate Social Responsibility Media Legal Information Universal Registration Document Patents Contact Copyright © Guerbet 2021 LinkedIn Twitter Instagram YouTube Cookie disclaimer Guerbet uses cookies to improve your experience and to analyze traffic patterns of visitors. By continuing your visit on this website without changing your settings, you consent to the use of cookies in accordance with our Cookie Policy. Find out more OK

Agenda Homepage Investors Agenda 2021 Half-year results Watch the webcast replay (Presentation of September 23, 2021) Download the presentation Agenda Here are the important upcoming events of Guerbet's shareholder calendar: February 11, 2021 2020 annual revenue March 24, 2021 2020 annual results April 22, 2021 Revenue at 1st quarter 2021 May 28, 2021 Annual general meeting 2021 July 22, 2021 Revenue at 2nd quarter 2021 September 22, 2021 2021 half-year results October 21, 2021 Revenue at 3rd quarter 2021 Go to General Meetings Media Legal Information Universal Registration Document Patents Contact Copyright © Guerbet 2021 LinkedIn Twitter Instagram YouTube Cookie disclaimer Guerbet uses cookies to improve your experience and to analyze traffic patterns of visitors. By continuing your visit on this website without changing your settings, you consent to the use of cookies in accordance with our Cookie Policy. Find out more OK